S'pore drug development gets another shot in the arm
One goal for EDDC will be to create projects that are attractive to multinational pharmaceutical companies
Add BT as a preferred source
Singapore
A*STAR officially opened the new Experimental Drug Development Centre (EDDC) on Wednesday to take more made-in-Singapore drugs from early-stage drug discovery to clinical trials and commercialisation.
Towards this end, the statutory board also launched the Target Translation Consortium (TTC), which coordinates drug discovery efforts in academia, healthcare institutions and government agencies, and consolidated three existing A*Star grants into the Singapore Therapeutics Development Review (STDR).
TRENDING NOW
Singapore is showing why cooling is the next investment asset
Nearly half of Apac’s wealthy expect market crash or correction, plan to rotate to cash: study
Shanda co-founder sells Tanglin Hill bungalow for S$76 million
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned
